What is Sales and Marketing Strategy of CSPC Pharmaceutical Group Company?

CSPC actively engages healthcare professionals through comprehensive medical education programs and scientific conferences. This approach fosters peer-to-peer interactions, highlighting the clinical benefits and efficacy of their innovative pharmaceutical offerings.

For specific products like Duomeisu, marketing efforts are concentrated on expanding coverage within core hospitals and penetrating lower-tier markets. This strategy also includes driving sales in regions affected by volume-based procurement (VBP).

While direct consumer digital marketing is less emphasized, the company leverages AI in drug development, signaling a data-driven strategy. Strategic partnerships and licensing agreements with global entities further support market share growth.

In 2024, CSPC conducted 79 announcements, 4 earnings briefings, 37 domestic and international strategy meetings, and 142 investor meetings. This robust investor relations activity demonstrates a commitment to transparency and stakeholder understanding.

The company's marketing mix has adapted to challenges like centralized procurement price cuts. This has led to a heightened focus on the value proposition of innovative drugs and broadening their reach through targeted professional channels.

CSPC's commitment to innovation is a core marketing differentiator, evidenced by its R&D expenditure. In 2024, this expenditure increased by 7.5% to RMB 5,191 million, representing approximately 21.9% of finished drug revenue.

The core of CSPC's brand positioning is its dedication to developing medicines that address critical unmet clinical needs worldwide. This focus drives their innovation pipeline and market differentiation.

With over 200 innovative drugs under development and significant R&D investment, CSPC positions itself as a leader in pharmaceutical science. This commitment to research is a primary driver of their brand identity.

CSPC's success in centralized procurement bids for 48 product types demonstrates a strategic effort to increase the affordability and accessibility of their high-quality medications for a larger patient population.

The consistent ranking among China's Top 500 Most Valuable Brands for over ten years highlights the strong market recognition and enduring value associated with the CSPC brand.

Through significant contributions to health and education initiatives and recognition for ESG efforts, CSPC integrates social responsibility into its brand narrative, enhancing its reputation and appeal.

CSPC actively manages competitive threats and market shifts by continuously strengthening its R&D capabilities and pursuing strategic partnerships, ensuring its continued relevance and growth.

CSPC's marketing strategy emphasizes direct engagement with healthcare professionals through scientific data dissemination and academic promotion.

Securing inclusion in national reimbursement lists and navigating procurement systems are critical components of their sales strategy.

Developing new formulations, like long-acting versions of existing drugs, is a key tactic to maintain market presence and drive sales.

International collaborations are pursued to enhance product development and expand global commercialization efforts.

The company actively adapts its strategies to address the pricing pressures introduced by systems like VBP.

Significant efforts are directed towards promoting newly launched innovative drugs and ensuring their market penetration.